Facilitated By

San Antonio Medical Foundation

News

  • Mid-level US Capital Markets Lawyer (Mandarin/Biotech experience desired)

    The team is working on a couple of listing transactions for biotech companies on Hong Kong/US stock, so the winning profile should ... San Antonio.

  • Positive Phase III results for Menarini's elacestrant - The Pharma Letter

    ... estrogen receptor degrader (SERD), are being presented during the San Antonio Breast Cancer Symposium (SABCS) being held from December 6-10.

  • Ellipses Pharma Presents Design of Newly Initiated Phase 1/2a Trial of Vosilasarm (EP0062 ...

    Tuesday December 6, 2022; 5:00 PM - 6:15 PM. Session name. Trial in Progress Session. Location. Henry B. González Convention, San Antonio, Texas ...

  • Ellipses Pharma Presents Design of Newly Initiated Phase 1/2a Trial of Vosilasarm (EP0062 ...

    ... advanced breast cancer at the San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas on Tuesday, 6 December from 5:00pm to 6:15pm CST.

  • San Antonio City Council considers a request to ban horse-drawn carriages | TPR

    San Antonio City Council members have been asked to consider a ban on horse-drawn carriages. City Councilmembers Jalen McKee-Rodriguez and Phylis ...